{"title":"甲状腺细胞学不确定的困境:可靠的诊断需要多少标志物?","authors":"S. Sciacchitano, A. Bartolazzi","doi":"10.21037/AOT.2018.07.01","DOIUrl":null,"url":null,"abstract":"Indeterminate cytology arises from the limit inherent in traditional cyto-morphological analysis. Numerous benign processes can cause subtle cellular or nuclear changes, sometimes indistinguishable from findings of well-differentiated carcinoma. Moreover, follicular carcinoma can be diagnosed only if the tumor’s ability to penetrate capsular or vascular structures is documented, but such a property can only be assessed at final histology.","PeriodicalId":92168,"journal":{"name":"Annals of thyroid","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/AOT.2018.07.01","citationCount":"0","resultStr":"{\"title\":\"The dilemma of indeterminate thyroid cytology: how many markers are needed for a reliable diagnosis?\",\"authors\":\"S. Sciacchitano, A. Bartolazzi\",\"doi\":\"10.21037/AOT.2018.07.01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Indeterminate cytology arises from the limit inherent in traditional cyto-morphological analysis. Numerous benign processes can cause subtle cellular or nuclear changes, sometimes indistinguishable from findings of well-differentiated carcinoma. Moreover, follicular carcinoma can be diagnosed only if the tumor’s ability to penetrate capsular or vascular structures is documented, but such a property can only be assessed at final histology.\",\"PeriodicalId\":92168,\"journal\":{\"name\":\"Annals of thyroid\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.21037/AOT.2018.07.01\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of thyroid\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21037/AOT.2018.07.01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of thyroid","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/AOT.2018.07.01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The dilemma of indeterminate thyroid cytology: how many markers are needed for a reliable diagnosis?
Indeterminate cytology arises from the limit inherent in traditional cyto-morphological analysis. Numerous benign processes can cause subtle cellular or nuclear changes, sometimes indistinguishable from findings of well-differentiated carcinoma. Moreover, follicular carcinoma can be diagnosed only if the tumor’s ability to penetrate capsular or vascular structures is documented, but such a property can only be assessed at final histology.